Latest Posts

27

Mar 24

Partex NV announces collaboration with Althea DRF Lifesciences to provide comprehensive end-to-end services to accelerate drug discovery and development

Frankfurt, Germany; 28 March 2024 – Partex Group, a pioneer in AI-driven drug discovery, announces a collaboration with Althea DRF...
Read More

18

Mar 24

Innovative AI technology in oncology: Partex Group presents results from a pilot project

During the German Cancer Congress 2024 in Berlin, the companies Innoplexus AG /Amrit AG, companies of Partex N.V., presented the...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More

Innoplexus Announces Appointment of Stratos Davlos as Chief Technology Officer (CTO) and Senior Vice President

Hoboken, New Jersey, September 16, 2019- Innoplexus Inc., a subsidiary of Innoplexus AG, announced today the appointment of Stratos Davlos as Chief Technology Officer (CTO) and Senior Vice President. Mr. Davlos is a highly accomplished artificial intelligence and machine learning executive with over 20 years of leadership experience.

Prior to joining Innoplexus, Mr. Davlos was the Vice President of Watson, AI & Engineering at IBM. His AI-focused career spans many years of executive technology management and development at among others Reliance Jio and Apple. Mr. Davlos holds many innovations, patents and has received many honors and awards.

“We are very excited to welcome Stratos to Innoplexus at such an important time as we roll out our AI-powered platform for Drug Discovery and Development for various industry stakeholders. His expertise and extensive experience will help us accelerate scaling our AI,“ said Dr. Gunjan Bhardwaj, Founder, and CEO of Innoplexus.

Stratos will be based in California in his global role and will build an Innoplexus Research Lab in the Valley. “I am excited to be a part of a purpose-driven company and continue to innovate with AI for effective and efficient drug discovery. Together with Innoplexus, we will put a dent in the universe for the service of humanity “, said Stratos.

Featured News

Strategic partnership announcement: Innoplexus holding company Partex NV is pleased to announce a one-of-its-kind collaboration with Anavex Life science corp. for Artificial Intelligence (AI) enabled drug development and healthcare sales marketing

Strategic partnership announcement: Innoplexus holding company Partex NV is pleased

Exciting News! Anavex Life Sciences and Partex NV Announce Strategic Partnership to Enhance Patient Experience. Anavex Life Sciences Corp. and Partex NV N.V. Group are pleased to announce…